PACTT congratulates CHUV MassChallenge laureates HaYa and Lymphatica
PACTT is proud to announce that HaYa and Lymhatica, two start-up projects from the University Hospital of Lausanne (CHUV), are amongst the gold winners of the MassChallenge Switzerland.
HaYa Therapeutics is developing a first-in-class biopharmaceutical therapy to treat heart failure. The project is the result of a strong and dynamic collaboration between Thierry Pedrazzini (right), Samir Ounzain (center) and Daniel Blessing (left).
Lymphatica Medtech SA, founded by Marco Pisano (right) and Valentina Triacca (center), is developing a micropump-based medical device for treatment of lymphedema, a chronic, disabling side effect of anti-cancer therapies. Marco Pisano was supported by the spring 2016 InnoTREK grant.
PACTT wishes full success to both teams!
par Jelena Cvetanovic - PACTT